MA35406B1 - Combinaison comprenant de l'uméclidinium et un corticoïde - Google Patents

Combinaison comprenant de l'uméclidinium et un corticoïde

Info

Publication number: MA35406B1
Authority: MA; Morocco
Prior art keywords: umeclidinium; corticosteroid; combination
Prior art date: 2011-06-08

Application number

MA36643A

Other languages

English (en)

Inventor

Glenn Crater

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-06-08

Filing date

2014-01-03

Publication date

2014-09-01

2014-01-03 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2014-09-01 Publication of MA35406B1 publication Critical patent/MA35406B1/fr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Otolaryngology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Steroid Compounds (AREA)

MA36643A 2011-06-08 2014-01-03 Combinaison comprenant de l'uméclidinium et un corticoïde MA35406B1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201161494600P	2011-06-08	2011-06-08
PCT/EP2012/060444 WO2012168161A1 (fr)	2011-06-08	2012-06-01	Combinaison comprenant de l'uméclidinium et un corticoïde

Publications (1)

Publication Number	Publication Date
MA35406B1 true MA35406B1 (fr)	2014-09-01

Family

ID=46201674

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA36643A MA35406B1 (fr)	2011-06-08	2014-01-03	Combinaison comprenant de l'uméclidinium et un corticoïde

Country Status (19)

Country	Link
US (1)	US20140113888A1 (fr)
EP (1)	EP2717868A1 (fr)
JP (1)	JP2014516062A (fr)
KR (1)	KR20140041699A (fr)
CN (1)	CN103582477A (fr)
AU (1)	AU2012266541A1 (fr)
BR (1)	BR112013031572A2 (fr)
CA (1)	CA2838030A1 (fr)
CL (1)	CL2013003497A1 (fr)
CO (1)	CO6821951A2 (fr)
CR (1)	CR20130643A (fr)
DO (1)	DOP2013000290A (fr)
EA (1)	EA201391618A1 (fr)
IL (1)	IL229633A0 (fr)
MA (1)	MA35406B1 (fr)
MX (1)	MX2013014399A (fr)
PE (1)	PE20141048A1 (fr)
SG (1)	SG195262A1 (fr)
WO (1)	WO2012168161A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT3578169T (pt)	2009-02-26	2024-07-29	Glaxo Group Ltd	Formulações farmacêuticas compreendendo 4-{(1r)-2-[(2,6- diclorobenzil)oxi]etoxi}hexil)amino]-1-hidroxietil}-2- (hidroximetil)fenol
GB0921075D0 (en)	2009-12-01	2010-01-13	Glaxo Group Ltd	Novel combination of the therapeutic agents
WO2013100083A1 (fr)	2011-12-28	2013-07-04	旭化成イーマテリアルズ株式会社	Accumulateur redox ainsi que membrane électrolytique pour accumulateur redox
JP6267685B2 (ja)	2012-04-13	2018-01-24	グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅＩｎｔｅｌｌｅｃｔｕａｌＰｒｏｐｅｒｔｙＤｅｖｅｌｏｐｍｅｎｔＬｉｍｉｔｅｄ	集合粒子
GB201222679D0 (en)	2012-12-17	2013-01-30	Glaxo Group Ltd	Pharmaceutical combination products
GB201305825D0 (en)	2013-03-28	2013-05-15	Vectura Ltd	New use
EP4252742A3 (fr)	2014-05-28	2023-12-27	GlaxoSmithKline Intellectual Property Development Ltd	Furoate de fluticasone utilisé dans le traitement de la bpco
US20170119744A1 (en)	2014-06-18	2017-05-04	Cipla Limited	Pharmaceutical Composition Comprising a Beta-2-Agonist and Anticholinergic Agent
CN107200734B (zh) *	2016-03-18	2019-12-24	益方生物科技（上海）有限公司	奎宁环衍生物及其制备方法和用途
TR201712424A2 (tr) *	2017-08-21	2019-03-21	Arven Ilac Sanayi Ve Ticaret Anonim Sirketi	Kuru toz i̇nhalasyon bi̇leşi̇mleri̇
WO2021236570A1 (fr) *	2020-05-18	2021-11-25	Anovent Pharmaceutical (U.S.), Llc	Formulation pharmaceutique contenant du remdésivir et ses métabolites actifs pour inhalation de poudre sèche

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9004781D0 (en)	1990-03-02	1990-04-25	Glaxo Group Ltd	Device
US5569450A (en)	1993-03-17	1996-10-29	Minnesota Mining And Manufacturing Company	Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid
US6126919A (en)	1997-02-07	2000-10-03	3M Innovative Properties Company	Biocompatible compounds for pharmaceutical drug delivery systems
ES2292604T5 (es)	2000-08-05	2015-06-01	Glaxo Group Limited	Éster S-fluorometílico del ácido 6 ,9 -difluoro-17 -[(2-furanilcarbonil)oxi]-11 -hidroxi-16 -metil-3-oxo-androsta-1,4-dien-17 -carbotioico como agente antiinflamatorio
UA77656C2 (en) *	2001-04-07	2007-01-15	Glaxo Group Ltd	S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
GB0201677D0 (en)	2002-01-25	2002-03-13	Glaxo Group Ltd	Medicament dispenser
SE527191C2 (sv) *	2003-06-19	2006-01-17	Microdrug Ag	Inhalatoranordning samt kombinerade doser av tiotropium och fluticason
TWI363759B (en) *	2004-04-27	2012-05-11	Glaxo Group Ltd	Muscarinic acetylcholine receptor antagonists
PE20060826A1 (es) *	2004-12-06	2006-10-08	Smithkline Beecham Corp	Derivado oleofinico de 8-azoniabiciclo[3.2.1]octano y combinacion farmaceutica que lo comprende
GB0515584D0 (en)	2005-07-28	2005-09-07	Glaxo Group Ltd	Medicament dispenser
AR058289A1 (es)	2005-12-12	2008-01-30	Glaxo Group Ltd	Colector para ser usado en dispensador de medicamento
WO2009036243A1 (fr) *	2007-09-12	2009-03-19	Glaxo Group Limited	Nouvelle combinaison d'agents thérapeutiques
PT3578169T (pt) *	2009-02-26	2024-07-29	Glaxo Group Ltd	Formulações farmacêuticas compreendendo 4-{(1r)-2-[(2,6- diclorobenzil)oxi]etoxi}hexil)amino]-1-hidroxietil}-2- (hidroximetil)fenol
GB0921075D0 (en) *	2009-12-01	2010-01-13	Glaxo Group Ltd	Novel combination of the therapeutic agents

2012
- 2012-06-01 SG SG2013089123A patent/SG195262A1/en unknown
- 2012-06-01 KR KR1020147000491A patent/KR20140041699A/ko not_active Application Discontinuation
- 2012-06-01 PE PE2013002753A patent/PE20141048A1/es not_active Application Discontinuation
- 2012-06-01 US US14/124,276 patent/US20140113888A1/en not_active Abandoned
- 2012-06-01 CA CA2838030A patent/CA2838030A1/fr not_active Abandoned
- 2012-06-01 EP EP12725047.0A patent/EP2717868A1/fr not_active Withdrawn
- 2012-06-01 BR BR112013031572A patent/BR112013031572A2/pt not_active IP Right Cessation
- 2012-06-01 MX MX2013014399A patent/MX2013014399A/es unknown
- 2012-06-01 AU AU2012266541A patent/AU2012266541A1/en not_active Abandoned
- 2012-06-01 EA EA201391618A patent/EA201391618A1/ru unknown
- 2012-06-01 JP JP2014514008A patent/JP2014516062A/ja active Pending
- 2012-06-01 CN CN201280027664.6A patent/CN103582477A/zh active Pending
- 2012-06-01 WO PCT/EP2012/060444 patent/WO2012168161A1/fr active Application Filing
2013
- 2013-11-26 IL IL229633A patent/IL229633A0/en unknown
- 2013-12-05 CL CL2013003497A patent/CL2013003497A1/es unknown
- 2013-12-06 DO DO2013000290A patent/DOP2013000290A/es unknown
- 2013-12-09 CO CO13287946A patent/CO6821951A2/es not_active Application Discontinuation
- 2013-12-09 CR CR20130643A patent/CR20130643A/es unknown
2014
- 2014-01-03 MA MA36643A patent/MA35406B1/fr unknown

Also Published As

Publication number	Publication date
MX2013014399A (es)	2014-03-21
WO2012168161A1 (fr)	2012-12-13
US20140113888A1 (en)	2014-04-24
PE20141048A1 (es)	2014-09-08
DOP2013000290A (es)	2014-03-16
CR20130643A (es)	2014-02-04
KR20140041699A (ko)	2014-04-04
CN103582477A (zh)	2014-02-12
EP2717868A1 (fr)	2014-04-16
CL2013003497A1 (es)	2014-07-04
JP2014516062A (ja)	2014-07-07
NZ618166A (en)	2016-01-29
BR112013031572A2 (pt)	2017-03-21
EA201391618A1 (ru)	2014-05-30
CO6821951A2 (es)	2013-12-31
CA2838030A1 (fr)	2012-12-13
IL229633A0 (en)	2014-01-30
AU2012266541A1 (en)	2014-01-09
SG195262A1 (en)	2013-12-30

Publication	Publication Date	Title
MA35406B1 (fr)	2014-09-01	Combinaison comprenant de l'uméclidinium et un corticoïde
BR112013022766A2 (pt)	2016-12-06	método de administração de d-pirfenidona e kit
FR2980207B1 (fr)	2013-08-30	Composition comprenant du polyamide 66 et du polyamide 610
EP2688412A4 (fr)	2014-10-08	Agents insecticides et leurs utilisations
FR2986520B3 (fr)	2014-04-25	Enrouleur de tuyau et agencement d'enrouleur de tuyau
BR302012005955S1 (pt)	2014-08-05	"configuração aplicada a cadeira"
BR302012001925S1 (pt)	2014-08-26	"configuração aplicada em calota"
BR112014010152A2 (pt)	2017-04-25	formulação esporicida e lenço
BR112013015487A2 (pt)	2016-07-19	composições e métodos relacionados a carotenóides.
UA22179S (uk)	2011-08-25	Підставка для «метрової» піци
UA23089S (uk)	2012-05-10	Табурет «медуза»
UA25086S (uk)	2013-07-10	Диван «бранд»
UA25087S (uk)	2013-07-10	Диван «берсі»
UA25085S (uk)	2013-07-10	Диван «сван»
UA23968S (uk)	2012-11-26	Перстень «грань»
BR302012000203S1 (pt)	2014-12-02	"configuração aplicada em dispensador"
UA23875S (uk)	2012-10-25	Сувенір-оберіг «хрест»
UA22851S (uk)	2012-03-12	Підвісок «восьмигранник»
UA22176S (uk)	2011-08-25	Автомат «вулкан-м»
JP2013132569A5 (fr)	2015-01-15
FR2997720B3 (fr)	2015-11-27	Vanne d'arret
UA21954S (uk)	2011-06-10	Диван «берлін»
IT1404107B1 (it)	2013-11-08	Portamenu'.
UA22496S (uk)	2011-11-25	Емблема «холостячки»
UA22181S (uk)	2011-08-25	Емблема «аbidos»